[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Small Interfering RNA (siRNA) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

October 2023 | 101 pages | ID: G805DD0EB6ADEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Small Interfering RNA (siRNA) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Small interfering RNA (siRNA) is a kind of endogenous single stranded RNA with regulatory function found in Eukaryote, generally 18-25nt. It can cause the degradation of target mRNA and inhibit its translation through specific binding with target mRNA, so as to regulate the post transcriptional expression of genes. Recent studies have shown that miRNAs are involved in various regulatory pathways, including development, viral defense, hematopoietic processes, organ formation, cell proliferation and apoptosis, and fat metabolism. DIA-UP's advanced chemical synthesis technology can provide customers with products such as miRNA inhibitors, miRNA mimetics, miRNA negative controls, Agomir, and Antagonir.

The Global Info Research report includes an overview of the development of the Small Interfering RNA (siRNA) industry chain, the market status of Cancer (General Chemical Synthesis of siRNA, Sterol Modified Chemical Synthesis of siRNA), Infectious Diseases (General Chemical Synthesis of siRNA, Sterol Modified Chemical Synthesis of siRNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Small Interfering RNA (siRNA).

Regionally, the report analyzes the Small Interfering RNA (siRNA) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Small Interfering RNA (siRNA) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Small Interfering RNA (siRNA) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Small Interfering RNA (siRNA) industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., General Chemical Synthesis of siRNA, Sterol Modified Chemical Synthesis of siRNA).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Small Interfering RNA (siRNA) market.

Regional Analysis: The report involves examining the Small Interfering RNA (siRNA) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Small Interfering RNA (siRNA) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Small Interfering RNA (siRNA):

Company Analysis: Report covers individual Small Interfering RNA (siRNA) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Small Interfering RNA (siRNA) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Infectious Diseases).

Technology Analysis: Report covers specific technologies relevant to Small Interfering RNA (siRNA). It assesses the current state, advancements, and potential future developments in Small Interfering RNA (siRNA) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Small Interfering RNA (siRNA) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Small Interfering RNA (siRNA) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
  • General Chemical Synthesis of siRNA
  • Sterol Modified Chemical Synthesis of siRNA
Market segment by Application
  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others
Market segment by players, this report covers
  • Agilent Technologies
  • Merck KGaA
  • QIAGEN (Exiqon)
  • NanoString Technologies, Inc.
  • Dharmacon (Horizon Discovery Group)
  • Synlogic
  • GeneCopoeia, Inc.
  • New England Biolabs
  • Quantabio
  • NanoString Technologies, Inc.
  • BioGenex
  • SeqMatic LLC
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Small Interfering RNA (siRNA) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Small Interfering RNA (siRNA), with revenue, gross margin and global market share of Small Interfering RNA (siRNA) from 2018 to 2023.

Chapter 3, the Small Interfering RNA (siRNA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Small Interfering RNA (siRNA) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Small Interfering RNA (siRNA).

Chapter 13, to describe Small Interfering RNA (siRNA) research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Small Interfering RNA (siRNA)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Small Interfering RNA (siRNA) by Type
  1.3.1 Overview: Global Small Interfering RNA (siRNA) Market Size by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Global Small Interfering RNA (siRNA) Consumption Value Market Share by Type in 2022
  1.3.3 General Chemical Synthesis of siRNA
  1.3.4 Sterol Modified Chemical Synthesis of siRNA
1.4 Global Small Interfering RNA (siRNA) Market by Application
  1.4.1 Overview: Global Small Interfering RNA (siRNA) Market Size by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Cancer
  1.4.3 Infectious Diseases
  1.4.4 Immunological Disorder
  1.4.5 Cardiovascular Disease
  1.4.6 Neurological Disease
  1.4.7 Others
1.5 Global Small Interfering RNA (siRNA) Market Size & Forecast
1.6 Global Small Interfering RNA (siRNA) Market Size and Forecast by Region
  1.6.1 Global Small Interfering RNA (siRNA) Market Size by Region: 2018 VS 2022 VS 2029
  1.6.2 Global Small Interfering RNA (siRNA) Market Size by Region, (2018-2029)
  1.6.3 North America Small Interfering RNA (siRNA) Market Size and Prospect (2018-2029)
  1.6.4 Europe Small Interfering RNA (siRNA) Market Size and Prospect (2018-2029)
  1.6.5 Asia-Pacific Small Interfering RNA (siRNA) Market Size and Prospect (2018-2029)
  1.6.6 South America Small Interfering RNA (siRNA) Market Size and Prospect (2018-2029)
  1.6.7 Middle East and Africa Small Interfering RNA (siRNA) Market Size and Prospect (2018-2029)

2 COMPANY PROFILES

2.1 Agilent Technologies
  2.1.1 Agilent Technologies Details
  2.1.2 Agilent Technologies Major Business
  2.1.3 Agilent Technologies Small Interfering RNA (siRNA) Product and Solutions
  2.1.4 Agilent Technologies Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Merck KGaA
  2.2.1 Merck KGaA Details
  2.2.2 Merck KGaA Major Business
  2.2.3 Merck KGaA Small Interfering RNA (siRNA) Product and Solutions
  2.2.4 Merck KGaA Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 QIAGEN (Exiqon)
  2.3.1 QIAGEN (Exiqon) Details
  2.3.2 QIAGEN (Exiqon) Major Business
  2.3.3 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Product and Solutions
  2.3.4 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 QIAGEN (Exiqon) Recent Developments and Future Plans
2.4 NanoString Technologies, Inc.
  2.4.1 NanoString Technologies, Inc. Details
  2.4.2 NanoString Technologies, Inc. Major Business
  2.4.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product and Solutions
  2.4.4 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 NanoString Technologies, Inc. Recent Developments and Future Plans
2.5 Dharmacon (Horizon Discovery Group)
  2.5.1 Dharmacon (Horizon Discovery Group) Details
  2.5.2 Dharmacon (Horizon Discovery Group) Major Business
  2.5.3 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Product and Solutions
  2.5.4 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Dharmacon (Horizon Discovery Group) Recent Developments and Future Plans
2.6 Synlogic
  2.6.1 Synlogic Details
  2.6.2 Synlogic Major Business
  2.6.3 Synlogic Small Interfering RNA (siRNA) Product and Solutions
  2.6.4 Synlogic Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Synlogic Recent Developments and Future Plans
2.7 GeneCopoeia, Inc.
  2.7.1 GeneCopoeia, Inc. Details
  2.7.2 GeneCopoeia, Inc. Major Business
  2.7.3 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Product and Solutions
  2.7.4 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 GeneCopoeia, Inc. Recent Developments and Future Plans
2.8 New England Biolabs
  2.8.1 New England Biolabs Details
  2.8.2 New England Biolabs Major Business
  2.8.3 New England Biolabs Small Interfering RNA (siRNA) Product and Solutions
  2.8.4 New England Biolabs Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 New England Biolabs Recent Developments and Future Plans
2.9 Quantabio
  2.9.1 Quantabio Details
  2.9.2 Quantabio Major Business
  2.9.3 Quantabio Small Interfering RNA (siRNA) Product and Solutions
  2.9.4 Quantabio Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Quantabio Recent Developments and Future Plans
2.10 NanoString Technologies, Inc.
  2.10.1 NanoString Technologies, Inc. Details
  2.10.2 NanoString Technologies, Inc. Major Business
  2.10.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product and Solutions
  2.10.4 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 NanoString Technologies, Inc. Recent Developments and Future Plans
2.11 BioGenex
  2.11.1 BioGenex Details
  2.11.2 BioGenex Major Business
  2.11.3 BioGenex Small Interfering RNA (siRNA) Product and Solutions
  2.11.4 BioGenex Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 BioGenex Recent Developments and Future Plans
2.12 SeqMatic LLC
  2.12.1 SeqMatic LLC Details
  2.12.2 SeqMatic LLC Major Business
  2.12.3 SeqMatic LLC Small Interfering RNA (siRNA) Product and Solutions
  2.12.4 SeqMatic LLC Small Interfering RNA (siRNA) Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 SeqMatic LLC Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Small Interfering RNA (siRNA) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
  3.2.1 Market Share of Small Interfering RNA (siRNA) by Company Revenue
  3.2.2 Top 3 Small Interfering RNA (siRNA) Players Market Share in 2022
  3.2.3 Top 6 Small Interfering RNA (siRNA) Players Market Share in 2022
3.3 Small Interfering RNA (siRNA) Market: Overall Company Footprint Analysis
  3.3.1 Small Interfering RNA (siRNA) Market: Region Footprint
  3.3.2 Small Interfering RNA (siRNA) Market: Company Product Type Footprint
  3.3.3 Small Interfering RNA (siRNA) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Small Interfering RNA (siRNA) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Small Interfering RNA (siRNA) Market Forecast by Type (2024-2029)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Small Interfering RNA (siRNA) Consumption Value Market Share by Application (2018-2023)
5.2 Global Small Interfering RNA (siRNA) Market Forecast by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Small Interfering RNA (siRNA) Consumption Value by Type (2018-2029)
6.2 North America Small Interfering RNA (siRNA) Consumption Value by Application (2018-2029)
6.3 North America Small Interfering RNA (siRNA) Market Size by Country
  6.3.1 North America Small Interfering RNA (siRNA) Consumption Value by Country (2018-2029)
  6.3.2 United States Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  6.3.3 Canada Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  6.3.4 Mexico Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)

7 EUROPE

7.1 Europe Small Interfering RNA (siRNA) Consumption Value by Type (2018-2029)
7.2 Europe Small Interfering RNA (siRNA) Consumption Value by Application (2018-2029)
7.3 Europe Small Interfering RNA (siRNA) Market Size by Country
  7.3.1 Europe Small Interfering RNA (siRNA) Consumption Value by Country (2018-2029)
  7.3.2 Germany Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  7.3.3 France Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  7.3.4 United Kingdom Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  7.3.5 Russia Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  7.3.6 Italy Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)

8 ASIA-PACIFIC

8.1 Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region
  8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Region (2018-2029)
  8.3.2 China Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  8.3.3 Japan Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  8.3.4 South Korea Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  8.3.5 India Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  8.3.6 Southeast Asia Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  8.3.7 Australia Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)

9 SOUTH AMERICA

9.1 South America Small Interfering RNA (siRNA) Consumption Value by Type (2018-2029)
9.2 South America Small Interfering RNA (siRNA) Consumption Value by Application (2018-2029)
9.3 South America Small Interfering RNA (siRNA) Market Size by Country
  9.3.1 South America Small Interfering RNA (siRNA) Consumption Value by Country (2018-2029)
  9.3.2 Brazil Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  9.3.3 Argentina Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country
  10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Country (2018-2029)
  10.3.2 Turkey Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  10.3.3 Saudi Arabia Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)
  10.3.4 UAE Small Interfering RNA (siRNA) Market Size and Forecast (2018-2029)

11 MARKET DYNAMICS

11.1 Small Interfering RNA (siRNA) Market Drivers
11.2 Small Interfering RNA (siRNA) Market Restraints
11.3 Small Interfering RNA (siRNA) Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Small Interfering RNA (siRNA) Industry Chain
12.2 Small Interfering RNA (siRNA) Upstream Analysis
12.3 Small Interfering RNA (siRNA) Midstream Analysis
12.4 Small Interfering RNA (siRNA) Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION


14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Small Interfering RNA (siRNA) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Small Interfering RNA (siRNA) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Small Interfering RNA (siRNA) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Small Interfering RNA (siRNA) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies Small Interfering RNA (siRNA) Product and Solutions
Table 8. Agilent Technologies Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Small Interfering RNA (siRNA) Product and Solutions
Table 13. Merck KGaA Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. QIAGEN (Exiqon) Company Information, Head Office, and Major Competitors
Table 16. QIAGEN (Exiqon) Major Business
Table 17. QIAGEN (Exiqon) Small Interfering RNA (siRNA) Product and Solutions
Table 18. QIAGEN (Exiqon) Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. QIAGEN (Exiqon) Recent Developments and Future Plans
Table 20. NanoString Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 21. NanoString Technologies, Inc. Major Business
Table 22. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product and Solutions
Table 23. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. NanoString Technologies, Inc. Recent Developments and Future Plans
Table 25. Dharmacon (Horizon Discovery Group) Company Information, Head Office, and Major Competitors
Table 26. Dharmacon (Horizon Discovery Group) Major Business
Table 27. Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Product and Solutions
Table 28. Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Dharmacon (Horizon Discovery Group) Recent Developments and Future Plans
Table 30. Synlogic Company Information, Head Office, and Major Competitors
Table 31. Synlogic Major Business
Table 32. Synlogic Small Interfering RNA (siRNA) Product and Solutions
Table 33. Synlogic Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Synlogic Recent Developments and Future Plans
Table 35. GeneCopoeia, Inc. Company Information, Head Office, and Major Competitors
Table 36. GeneCopoeia, Inc. Major Business
Table 37. GeneCopoeia, Inc. Small Interfering RNA (siRNA) Product and Solutions
Table 38. GeneCopoeia, Inc. Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GeneCopoeia, Inc. Recent Developments and Future Plans
Table 40. New England Biolabs Company Information, Head Office, and Major Competitors
Table 41. New England Biolabs Major Business
Table 42. New England Biolabs Small Interfering RNA (siRNA) Product and Solutions
Table 43. New England Biolabs Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. New England Biolabs Recent Developments and Future Plans
Table 45. Quantabio Company Information, Head Office, and Major Competitors
Table 46. Quantabio Major Business
Table 47. Quantabio Small Interfering RNA (siRNA) Product and Solutions
Table 48. Quantabio Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Quantabio Recent Developments and Future Plans
Table 50. NanoString Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 51. NanoString Technologies, Inc. Major Business
Table 52. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product and Solutions
Table 53. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. NanoString Technologies, Inc. Recent Developments and Future Plans
Table 55. BioGenex Company Information, Head Office, and Major Competitors
Table 56. BioGenex Major Business
Table 57. BioGenex Small Interfering RNA (siRNA) Product and Solutions
Table 58. BioGenex Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BioGenex Recent Developments and Future Plans
Table 60. SeqMatic LLC Company Information, Head Office, and Major Competitors
Table 61. SeqMatic LLC Major Business
Table 62. SeqMatic LLC Small Interfering RNA (siRNA) Product and Solutions
Table 63. SeqMatic LLC Small Interfering RNA (siRNA) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. SeqMatic LLC Recent Developments and Future Plans
Table 65. Global Small Interfering RNA (siRNA) Revenue (USD Million) by Players (2018-2023)
Table 66. Global Small Interfering RNA (siRNA) Revenue Share by Players (2018-2023)
Table 67. Breakdown of Small Interfering RNA (siRNA) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Small Interfering RNA (siRNA), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Small Interfering RNA (siRNA) Players
Table 70. Small Interfering RNA (siRNA) Market: Company Product Type Footprint
Table 71. Small Interfering RNA (siRNA) Market: Company Product Application Footprint
Table 72. Small Interfering RNA (siRNA) New Market Entrants and Barriers to Market Entry
Table 73. Small Interfering RNA (siRNA) Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Small Interfering RNA (siRNA) Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Small Interfering RNA (siRNA) Consumption Value Share by Type (2018-2023)
Table 76. Global Small Interfering RNA (siRNA) Consumption Value Forecast by Type (2024-2029)
Table 77. Global Small Interfering RNA (siRNA) Consumption Value by Application (2018-2023)
Table 78. Global Small Interfering RNA (siRNA) Consumption Value Forecast by Application (2024-2029)
Table 79. North America Small Interfering RNA (siRNA) Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Small Interfering RNA (siRNA) Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Small Interfering RNA (siRNA) Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Small Interfering RNA (siRNA) Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Small Interfering RNA (siRNA) Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Small Interfering RNA (siRNA) Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Small Interfering RNA (siRNA) Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Small Interfering RNA (siRNA) Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Small Interfering RNA (siRNA) Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Small Interfering RNA (siRNA) Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Small Interfering RNA (siRNA) Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Small Interfering RNA (siRNA) Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Small Interfering RNA (siRNA) Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Small Interfering RNA (siRNA) Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Small Interfering RNA (siRNA) Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Small Interfering RNA (siRNA) Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Small Interfering RNA (siRNA) Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Small Interfering RNA (siRNA) Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Small Interfering RNA (siRNA) Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Small Interfering RNA (siRNA) Raw Material
Table 110. Key Suppliers of Small Interfering RNA (siRNA) Raw Materials

LIST OF FIGURES

Figure 1. Small Interfering RNA (siRNA) Picture
Figure 2. Global Small Interfering RNA (siRNA) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Small Interfering RNA (siRNA) Consumption Value Market Share by Type in 2022
Figure 4. General Chemical Synthesis of siRNA
Figure 5. Sterol Modified Chemical Synthesis of siRNA
Figure 6. Global Small Interfering RNA (siRNA) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Small Interfering RNA (siRNA) Consumption Value Market Share by Application in 2022
Figure 8. Cancer Picture
Figure 9. Infectious Diseases Picture
Figure 10. Immunological Disorder Picture
Figure 11. Cardiovascular Disease Picture
Figure 12. Neurological Disease Picture
Figure 13. Others Picture
Figure 14. Global Small Interfering RNA (siRNA) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Small Interfering RNA (siRNA) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Small Interfering RNA (siRNA) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Small Interfering RNA (siRNA) Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Small Interfering RNA (siRNA) Consumption Value Market Share by Region in 2022
Figure 19. North America Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Small Interfering RNA (siRNA) Revenue Share by Players in 2022
Figure 25. Small Interfering RNA (siRNA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Small Interfering RNA (siRNA) Market Share in 2022
Figure 27. Global Top 6 Players Small Interfering RNA (siRNA) Market Share in 2022
Figure 28. Global Small Interfering RNA (siRNA) Consumption Value Share by Type (2018-2023)
Figure 29. Global Small Interfering RNA (siRNA) Market Share Forecast by Type (2024-2029)
Figure 30. Global Small Interfering RNA (siRNA) Consumption Value Share by Application (2018-2023)
Figure 31. Global Small Interfering RNA (siRNA) Market Share Forecast by Application (2024-2029)
Figure 32. North America Small Interfering RNA (siRNA) Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Small Interfering RNA (siRNA) Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Small Interfering RNA (siRNA) Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Small Interfering RNA (siRNA) Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Small Interfering RNA (siRNA) Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Small Interfering RNA (siRNA) Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 42. France Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Small Interfering RNA (siRNA) Consumption Value Market Share by Region (2018-2029)
Figure 49. China Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 52. India Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Small Interfering RNA (siRNA) Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Small Interfering RNA (siRNA) Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Small Interfering RNA (siRNA) Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Small Interfering RNA (siRNA) Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Small Interfering RNA (siRNA) Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Small Interfering RNA (siRNA) Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Small Interfering RNA (siRNA) Consumption Value (2018-2029) & (USD Million)
Figure 66. Small Interfering RNA (siRNA) Market Drivers
Figure 67. Small Interfering RNA (siRNA) Market Restraints
Figure 68. Small Interfering RNA (siRNA) Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Small Interfering RNA (siRNA) in 2022
Figure 71. Manufacturing Process Analysis of Small Interfering RNA (siRNA)
Figure 72. Small Interfering RNA (siRNA) Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source


More Publications